Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 19 - Drugs for skeletal disorders
Patents for A61P 19 - Drugs for skeletal disorders (81,981)
10/2002
10/02/2002EP1244700A2 Vesicle trafficking proteins
10/02/2002EP1244693A1 Compositions for treating abnormalities in glomerular filtration, patent ductus arteriosus and osteoporosis
10/02/2002EP1244683A1 21 human secreted proteins
10/02/2002EP1244679A1 Purine derivatives
10/02/2002EP1244672A1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors
10/02/2002EP1244669A1 Pyrazolopyrazines and their use as adenosine antagonists
10/02/2002EP1244657A2 Sulfonamides and derivatives thereof that modulate the activity of endothelin
10/02/2002EP1244653A1 Non peptide tachykinin receptor antagonists
10/02/2002EP1244649A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244648A1 Chemokine receptor binding heterocyclic compounds
10/02/2002EP1244647A1 Quinazoline derivatives as vegf inhibitors
10/02/2002EP1244643A1 Tryptase inhibitors
10/02/2002EP1244640A1 Oxazolidinone derivatives
10/02/2002EP1244628A1 Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
10/02/2002EP1244626A2 Caspase inhibitors and uses thereof
10/02/2002EP1244625A1 4-pyridinyl-n-acyl-l-phenylalanines
10/02/2002EP1244621A1 Nitrile derivatives as cathepsin k inhibitors
10/02/2002EP1244620A1 Cyclic amp-specific phosphodiesterase inhibitors
10/02/2002EP1244619A1 Pyrrolidines which inhibit camp-specific pde
10/02/2002EP1244614A2 Tryptase inhibitors
10/02/2002EP1244461A2 INHIBITION OF GSK-3$g(b)
10/02/2002EP1244457A2 Methods and compositions related to modulators of annexin and cartilage homeostasis
10/02/2002EP1244441A1 Use of trimebutine for treating pain
10/02/2002EP1244388A2 Intervertebral disc treatment devices and methods
10/02/2002EP1144459B1 Cross-linked hyaluronic acids and medical uses thereof
10/02/2002EP1064009B1 Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as an estrogen-like organ-selective medicament without uterotropic effects
10/02/2002DE10112924A1 1-Butansäurederivate, pharmazeutische Zusammensetzungen enthaltend solche Derivate und Verwendungen solcher Derivate 1-butanoic acid derivatives, pharmaceutical compositions containing such derivatives and uses of such derivatives
10/02/2002CN1372594A OX2 receptor homologs
10/02/2002CN1372569A Keratinocyte growth factor-2
10/02/2002CN1372565A Non-aromatic estrogenic steroids with hydrocarbon substituent in position 11
10/02/2002CN1372559A Naphthyridine derivatives processes for their preparation their use and pharmaceutical compositions comprising them
10/02/2002CN1372556A Heterocyclic compound inhibiting angiogenesis
10/02/2002CN1372555A Compositions and therapeutic mehtods involving isoflavones and analogues thereof
10/02/2002CN1372544A 新颖的维生素d类似物 Novel analogues of vitamin d
10/02/2002CN1372543A new vitamin derivatives with cyclic substructures in the side chains, method and intermediates for their production and their use in the preparation of medicaments
10/02/2002CN1372474A Methods for preventing or attenuating patthoangiogenic conditions
10/02/2002CN1371743A Songqi pain-stopping ointment
10/02/2002CN1371731A Medicine for treating arthritis and bone injury disease
10/02/2002CN1371720A Wind-removing pain-eliminating disinfecting soft extract
10/02/2002CN1091612C Homothermal adhesive plaster promoting blood circulation to stop pain and preparation process thereof
10/02/2002CN1091609C Tincture for treating rheumatoid arthritis and its preparing process
10/01/2002WO2001076630A1 Diagnostics and remedies for rheumatoid arthritis
10/01/2002US6458934 Grafted complementarity determining regions to mouse monoclonal antibodies; amino acid replacements; autoimmune disease treatment and immunosuppressants; side effect reduction
10/01/2002US6458829 Substituted γ-phenyl-Δ-lactones and analogs thereof and uses related thereto
10/01/2002US6458827 Adjustent of conformation equilibrium; active materials
10/01/2002US6458822 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
10/01/2002US6458819 Thiazolium compounds and treatments of disorders associated with protein aging
10/01/2002US6458814 Vitronectin receptor antagonists and are useful in the treatment of osteoporosis: treatment of inflammation, cancer and cardiovascular disorders, such as atherosclerosis and restenosis, and diseases wherein bone resorption is a factor,
10/01/2002US6458813 2-cyclohexyloxy-5-(2-chlorophenylcarbonylamino)pyridine, for example; treating inflammation, pain, diabetes, cancer
10/01/2002US6458810 Pharmaceutically active isoindoline derivatives
10/01/2002US6458801 Benzofurane derivatives, preparation method, use as medicines and pharmaceutical compositions containing same
10/01/2002US6458787 Novel pyrrolidine compounds that are potent and selective inhibitors of pde4, as well as methods of making the same, are disclosed. use of the compounds in the treatment of inflammatory diseases and other diseases involving elevated
10/01/2002US6458764 GRF analogs with increased biological potency
10/01/2002US6458763 Bone sialoprotein-based compositions for enhancing connective tissue repair
10/01/2002US6458586 Replication of defective vectors with mutations and deletions; gene therapy, vaccines, genetic engineering
10/01/2002US6458383 Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin
10/01/2002CA2404919A1 Diagnostic and therapeutic agents for rheumatoid arthritis
09/2002
09/26/2002WO2002074982A1 Methods involving the use of capg as a diagnostic marker and methods for the identification of capg modulators for the treatment and prevention of osteoporosis and related disease states
09/26/2002WO2002074955A2 Oligonucleotides for regulating the gene coding for tnf$g(a) and/or genes controlled thereby and use thereof
09/26/2002WO2002074924A2 Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof
09/26/2002WO2002074913A2 Nucleic acid-associated proteins
09/26/2002WO2002074784A2 Novel use of a peptide class of compound for treating non neuropathic inflammatory pain
09/26/2002WO2002074771A1 Tricyclic heterocyclic compound, process for producing the same, and use
09/26/2002WO2002074770A1 Triazaspiro[5.5]undecane derivatives and drugs containing the same as the active ingredient
09/26/2002WO2002074767A1 Metalloproteinase inhibitors
09/26/2002WO2002074763A1 Benzimidazol derivatives modulate chemokine receptors
09/26/2002WO2002074754A1 New spirotricyclic derivatives and their use as phosphodiesterase-7 inhibitors
09/26/2002WO2002074752A1 Metalloproteinase inhibitors
09/26/2002WO2002074751A1 Metalloproteinase inhibitors
09/26/2002WO2002074750A1 Metalloproteinase inhibitors
09/26/2002WO2002074749A1 Metalloproteinase inhibitors
09/26/2002WO2002074748A1 Metalloproteinase inhibitors
09/26/2002WO2002074743A1 Aryl-substituted alicyclic compound and medical composition comprising the same
09/26/2002WO2002074738A2 Spiro-cyclic beta-amino acid derivatives as inhibitors of matrix metalloproteinases and tnf-alpha converting enzyme (tage)
09/26/2002WO2002074733A2 Tryptase-inhibitors
09/26/2002WO2002074730A1 INHIBITORS OF INTEGRIN αvβ¿6?
09/26/2002WO2002074725A1 Novel ligands of nuclear receptor superfamily, process for producing the same and use thereof
09/26/2002WO2002074346A2 Targeting chemical compounds to cells
09/26/2002WO2002074318A1 Il-12 expression controlling agents
09/26/2002WO2002074308A1 Composition for the prevention of osteoporosis comprising a combination of isoflavones and polyunsaturated fatty acids
09/26/2002WO2002074305A1 Use of a substantially cell membrane impermeable compound for treating arthritis
09/26/2002WO2002074301A1 Method of using pyruvate and/or its derivatives for the treatment of cytokine-mediated inflammatory conditions
09/26/2002WO2002074298A1 Il-6 production inhibitors
09/26/2002WO2002074292A2 Hormone replacement therapy
09/26/2002WO2002074243A2 Methods and compositions for the treatment and/or diagnosis of neurological diseases and disorders
09/26/2002WO2002074234A2 Method and composition for treatment of skeletal dysplasias
09/26/2002WO2002074230A2 A dna molecule encoding a variant paraoxonase and uses thereof
09/26/2002WO2002060900A3 Antagonists of mcp-1 function and methods of use thereof
09/26/2002WO2002060382A3 Novel compounds and uses thereof
09/26/2002WO2002055517A3 4-(hetero)aryl substituted indolinones
09/26/2002WO2002055064A3 Mucopolysaccharidosis therapies
09/26/2002WO2002046214A3 Immunomodulatory protein derived from the yaba monkey tumor virus
09/26/2002WO2002032872A8 Nitrogenous aromatic ring compounds
09/26/2002WO2002032397A8 Electroprocessing in drug delivery and cell encapsulation
09/26/2002WO2002026954A3 Truncated phosphodiesterase-7 polypeptides
09/26/2002WO2002015918A3 Method and compositions for promoting osteogenesis
09/26/2002WO2001098332A3 Secreted redox proteins
09/26/2002WO2001087343A3 Combination therapy using cox-2 selective inhibitor and thromboxane inhibitor and compositions therefor
09/26/2002WO2001083775A3 Proteases
09/26/2002WO2001052847A8 Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
1 ... 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 ... 820